Search Results

Amyris, Inc. announced that it has completed the previously announced strategic transaction with Givaudan SA for the worldwide exclusive licensing of certain cosmetic ingredients, including Neossance® Squalane, the highest performant emollient, Neossance® Hemisqualane, the plant-based silicone alternative, and CleanScreen™, the sustainable sun protector.

Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming, announced the signing of a multi-program collaboration with Givaudan, the world’s leading Taste & Wellbeing and Fragrance & Beauty company.

Avantor, Inc. today announced the creation of a new Scientific Advisory Board (SAB), which will provide strategic guidance and consult on the Company’s mid- to long-term research and development efforts to deliver solutions for the life sciences industry, including biotech and pharma customers.

Amyris, Inc. announced financial results for the first quarter ended March 31, 2023.

Boston-based Ginkgo Bioworks has been having a banner year and doesn’t show any signs of stopping with its recent string of collaboration announcements.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the board of directors has been established for Magdalena Biosciences, Inc., the joint venture recently formed by Jaguar and Filament Health Corp.

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-MarketTM technology platform and clean beauty consumer brands, today announced financial results for the fourth quarter and full year ended December 31, 2022.